Medline Inc. (MDLN): Cash & Equivalents
$1.94B
As of 2025-12-31
$2.33B
As of 2026-06-27
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.94B | +874.4% | 2026-02-25, Balance as of period end |
| 2024-12-31 | $199.00M | n/a | 2026-02-25, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Medline Inc. (MDLN) | 2025-12-31 | $1.94B | +874.4% |
| Stryker Corp (SYK) | 2025-12-31 | $4.01B | +9.8% |
| Becton Dickinson & Co (BDX) | 2025-09-30 | $641.00M | -62.7% |
| Boston Scientific Corp (BSX) | 2025-12-31 | $1.97B | +374.6% |
| Baxter International Inc (BAX) | 2025-12-31 | $1.97B | +11.5% |
| Solventum Corp (SOLV) | 2025-12-31 | $878.00M | +15.2% |
| ResMed Inc (RMD) | 2026-06-30 | $1.47B | +21.5% |
| Dexcom Inc (DXCM) | 2025-12-31 | $917.70M | +51.4% |
| MiniMed Group, Inc. (MMED) | 2026-04-24 | $298.00M | n/m |
Compare MDLN, SYK, BDX, BSX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗